Canagliflozin, a New Sodium-Glucose Co-Transporter 2 Inhibitor, in the Treatment of Diabetes, Sarah A. Nisly, Denise M. Kolanczyk, Alison M. Walton
Alison M. Walton

Aspirin Dosing for the Prevention and Treatment of Ischemic Stroke: An Indication-Specific Review of the Literature, Alexander J. Ansara, Sarah A. Nisly, Sally A, Arif, Julia M. Koehler, Sarah T, Nordmeyer
Sarah A. Nisly

Tobramycin-Induced Hepatotoxicity, Sarah A. Nisly, Shaunta' M. Ray, Robert A. Moye
Sarah A. Nisly

Canagliflozin, a New Sodium-Glucose Co-Transporter 2 Inhibitor, in the Treatment of Diabetes, Sarah A. Nisly, Denise M. Kolanczyk, Alison M. Walton
Sarah A. Nisly

Simvastatin: A Risk Factor for Angioedema?, Sarah A. Nisly, Areeba Kara, Tamara B. Knight
Sarah A. Nisly

Canagliflozin, a New Sodium-Glucose Co-Transporter 2 Inhibitor, in the Treatment of Diabetes, Sarah A. Nisly, Denise M. Kolanczyk, Alison M. Walton
Scholarship and Professional Work – COPHS

Simvastatin: A Risk Factor for Angioedema?, Sarah A. Nisly, Areeba Kara, Tamara B. Knight
Scholarship and Professional Work – COPHS

Aspirin Dosing for the Prevention and Treatment of Ischemic Stroke: An Indication-Specific Review of the Literature, Alexander J. Ansara, Sarah A. Nisly, Sally A, Arif, Julia M. Koehler, Sarah T, Nordmeyer
Scholarship and Professional Work – COPHS

Tobramycin-Induced Hepatotoxicity, Sarah A. Nisly, Shaunta' M. Ray, Robert A. Moye
Scholarship and Professional Work – COPHS